Siga Technologies Inc (SIGA): Depreciation & Amortization
$562.6K
Year ended 2025-12-31
$590.5K
Trailing 12 months to 2026-06-30
+2.8%
3-year compound annual growth
+1.2%
5-year compound annual growth
+8.6%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $562.6K | +4.5% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $538.4K | 0.0% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $538.3K | +4.0% | 2026-03-10, From 2023-01-01 |
| 2022-12-31 | $517.6K | -0.9% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $522.4K | -1.4% | 2024-03-12, From 2021-01-01 |
| 2020-12-31 | $529.8K | +0.5% | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | $527.0K | +656.9% | 2022-03-03, From 2019-01-01 |
| 2018-12-31 | $69.6K | -47.3% | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | $132.2K | -24.1% | 2020-03-05, From 2017-01-01 |
| 2016-12-31 | $174.3K | -29.5% | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | $247.4K | -29.6% | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | $351.6K | -24.1% | 2017-03-07, From 2014-01-01 |
| 2013-12-31 | $463.1K | +10.4% | 2016-03-04, From 2013-01-01 |
| 2012-12-31 | $419.4K | -26.2% | 2015-03-06, From 2012-01-01 |
| 2011-12-31 | $568.3K | -9.1% | 2014-03-10, From 2011-01-01 |
| 2010-12-31 | $625.3K | +31.6% | 2013-05-15, From 2010-01-01 |
| 2009-12-31 | $475.1K | n/a | 2012-03-01, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Siga Technologies Inc (SIGA) | 2025-12-31 | $562.6K | +4.5% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | $10.12M | +6.2% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $9.26M | -26.0% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $1.37M | n/m |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $4.05M | -36.5% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $8.74M | -6.2% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | $307.0K | -6.7% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
Compare SIGA, CYTK, LAB, SPRY side by side · Screen every company in Pharmaceutical Preparations ↗